0
0
NEW DELHI – A brewing regulatory conflict has reached a boiling point as the All India Organisation of Chemists and Druggists (AIOCD) formally challenged a government proposal that would allow agricultural societies to stock and sell life-saving medicines. The dispute pits the government’s goal of “medicine for all” against the professional standards of the pharmaceutical industry, raising urgent questions about patient safety and the rise of “superbugs” in rural India.
On March 4, 2026, the AIOCD submitted a stern letter to Health Secretary Punya Salila Srivastava, demanding the immediate withdrawal of a proposal to grant restricted drug licenses to Primary Agricultural Credit Societies (PACS). The organization, which represents over 940,000 pharmacists, warns that allowing untrained staff to dispense medication in facilities that primarily handle pesticides and fertilizers is a “recipe for a public health catastrophe.”
The Proposal: Expanding Access or Diluting Safety?
The controversy stems from a December 2025 initiative by the Ministry of Cooperation. The ministry requested that the Ministry of Health and Family Welfare invoke Rules 62A and 62B of the Drugs and Cosmetics Rules, 1945. These colonial-era rules allow for “restricted licenses” to sell drugs in specific areas without the constant supervision of a registered pharmacist.
The government’s objective is to utilize the massive network of PACS—grassroots cooperatives that provide farmers with loans, seeds, and chemicals—to operate Pradhan Mantri Bhartiya Jan Aushadhi Kendras (PMBJKs). These generic medicine outlets have been a cornerstone of India’s healthcare strategy, offering drugs at 50% to 90% lower costs than branded alternatives.
While the government views the 63,000 PACS branches as a ready-made infrastructure to reach 100,000 underserved villages, the AIOCD argues the strategy is dangerously outdated.
“Medicines are life-saving products. They cannot be treated at par with agricultural chemicals,” stated AIOCD President J.S. Shinde and General Secretary Rajiv Singhal in their joint statement. “Permitting PACS to dispense drugs without professional oversight will weaken accountability and compromise drug control.”
The Risk of “Cross-Contamination” and Storage Failures
One of the most practical concerns raised by experts is the physical environment of a PACS facility. Unlike dedicated pharmacies, these societies often store volatile agricultural inputs.
-
Temperature Control: Many medicines, including certain antibiotics and respiratory drugs, require strict climate control. Most agricultural warehouses are not equipped to maintain the stable 20°C–25°C environment required for drug integrity.
-
Chemical Contamination: Storing pesticides and herbicides in the same vicinity as oral medications poses a significant risk of accidental contamination or toxic exposure.
The Silent Threat: Antimicrobial Resistance (AMR)
Beyond physical storage, the medical community is sounding the alarm on Antimicrobial Resistance (AMR). India is currently a global hotspot for AMR, a condition where bacteria evolve to resist the drugs designed to kill them. This crisis contributes to approximately 4.95 million deaths annually worldwide.
In India, the resistance levels of common bacteria like E. coli and Klebsiella have already crossed 70% and 80%, respectively. Public health experts argue that dispensing antibiotics through untrained agricultural staff—who may lack the training to identify unnecessary prescriptions or explain the importance of finishing a course—will fuel this “silent pandemic.”
A 2025 study conducted in Chennai highlighted that even in urban settings, 52% of pharmacies dispensed medications without proper justification. Expanding this lack of oversight to 63,000 rural credit societies could, according to the AIOCD, lead to a surge in medication errors and the proliferation of drug-resistant infections.
Expert Perspectives: The Role of the Pharmacist
Medical professionals emphasize that a pharmacist is more than a salesperson; they are the final “safety check” in the healthcare chain.
“Pharmacist supervision is a linchpin of safe practice,” notes current global health standards. This sentiment was echoed by Dr. Rajeev Singh Raghuvanshi, former Drug Controller General of India (DCGI), who previously mandated that no prescription medicine should be sold without the physical presence of a registered professional.
The Indian Pharmaceutical Association (IPA) has joined the chorus, noting that Section 42(a) of the Pharmacy Act explicitly requires a pharmacist’s presence during dispensing. Critics of the government’s plan argue that bypassing these laws via “restricted licenses” sets a dangerous precedent that values convenience over clinical safety.
The Counterpoint: The Rural Health Gap
The Ministry of Cooperation’s stance is rooted in a hard reality: rural India often lacks basic healthcare infrastructure. By September 2024, the PMBJK program had grown to 13,822 outlets, saving citizens an estimated ₹30,000 crore. However, thousands of villages remain miles away from the nearest licensed chemist.
Proponents of the PACS model argue that:
-
Affordability: Generic drugs are essential for the economic survival of rural farmers.
-
Infrastructure: Using existing credit societies is the fastest way to scale.
-
Restricted Scope: The licenses would only cover “Schedule K” drugs—specific medicines deemed safer for distribution in remote areas.
Comparison of Pharmacy Models
| Feature | Licensed Pharmacy (AIOCD) | Proposed PACS Model |
| Supervision | Registered Pharmacist (Required) | Non-professional staff |
| Storage | Regulated Temperature/Cleanliness | Warehouse/Agricultural setting |
| Patient Counseling | Dosage and interaction advice provided | Limited to no counseling |
| Primary Goal | Clinical safety and drug delivery | Rural access and credit support |
Looking Ahead: The Path Forward
The AIOCD has demanded that the Ministry of Health issue a clear advisory to all state drug controllers to stop the issuance of licenses under Rules 62A and 62B. They argue that with 900,000 registered pharmacists in India, there is no shortage of qualified professionals to man rural centers; rather, there is a lack of incentives to place them there.
Alternative solutions being discussed by stakeholders include:
-
Mobile Pharmacy Units: Staffed by pharmacists to visit clusters of villages.
-
Pharmacist Incentives: Government subsidies for young pharmacists to open shops in “dark zones.”
-
Hybrid Models: Ensuring every PACS-based medicine center has a tele-pharmacy link to a qualified professional.
As the debate continues, the fundamental question remains: can India bridge the gap in rural healthcare without compromising the very safety standards designed to protect its citizens?
References
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
